Bioterrorism Week
Susan Hasty, Publisher
Table of Contents . . . November 8th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Bioterrorism Week | Other Publications
Anthrax - Government to provide more funding for Anthim, an antianthrax drug
Anthrax Vaccine - Capsule of Bacillus anthracis behaves as type 2 antigen
Bioterrorism - Report finds pharma, government and academia agree on bioterrorism danger
Pneumonic Plague - U.S. NIH allergy institute awards $50 million for recombinant protein vaccine
Tularemia Vaccine - Sublethal Francisella infection causes only marginal immunity
Collaborations - SAIS and CombiMatrix to jointly develop biothreat identification microarrays
Diagnostics - Bioassays company announces U.S. Army contract, new kinase Activity Assays
Finance - Biotechnology company closes $50 million in series B financing
Food-Borne Illness - FDA releases 2004 produce safety action plan
Mergers and Acquisitions - Food safety company acquires German distributor
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
